Cowen And Company, LLC Halozyme Therapeutics, Inc. Transaction History

Cowen And Company, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$33.32 - $42.1 $1.8 Million - $2.27 Million	54,034 New	54,034 $2 Million
Q2 2021 Aug 13, 2021	BUY	$38.84 - $51.31 $115,238 - $152,236	2,967 Added 39.49%	10,480 $476,000
Q1 2021 May 04, 2021	BUY	$39.51 - $51.45 $296,838 - $386,543	7,513 New	7,513 $313,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.